Alberta’s premier says a decision this week by British health officials is in line with her government’s plans on transgender healthcare. Under a new policy, U.K. patients under the age of 18 will no longer be able to access puberty blockers unless they enroll in a clinical trial. That decision follows a four year review of published research, but critics say politics are at play. Heather Yourex-West reports.
Danielle Smith
Danielle Smith says U.K. decision to limit access to puberty blockers is example for Alberta
More Videos
-
Queer chamber of commerce has economic concerns over gender identity legislation
-
New Alberta family physician compensation model unveiled
-
Canadian premiers at odds with tariff talks
-
Less politicking, more building: Calgarians frustrated over persistent Green Line delays
-
Net-zero electricity target pushed to 2050 as Alberta vows legal challenge
-
Alberta unveils red zone border patrol plan to combat illegal activity
You are viewing an Accelerated Mobile Webpage.
View Original Article